Safety and Efficacy of Generic Sofosbuvir and Ribavirin for Treatment-naive Genotype 2 Chronic Hepatitis C

Clinical trial NCT03453346 · COMPLETED

Trial details

NCT number: NCT03453346
Sponsor: Kawin Technology Share-holding Co., Ltd.
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Hepatitis C, Chronic Hepatitis C Virus Infection, Response to Therapy of

Start date: 2016-08-05
Primary completion: 2017-03-18
Enrollment: 136

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.